Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
85.30
-0.34 (-0.40%)
Nov 21, 2024, 1:49 PM EST - Market open
Intra-Cellular Therapies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 464.31 | 147.77 | 148.62 | 92.37 | 60.05 | 107.64 | Upgrade
|
| Short-Term Investments | 542.25 | 350.17 | 443.29 | 319.97 | 597.4 | 116.37 | Upgrade
|
| Cash & Short-Term Investments | 1,007 | 497.94 | 591.91 | 412.33 | 657.45 | 224.01 | Upgrade
|
| Cash Growth | 104.16% | -15.87% | 43.55% | -37.28% | 193.49% | -35.54% | Upgrade
|
| Receivables | 145.61 | 114.02 | 75.19 | 20.16 | 10.76 | - | Upgrade
|
| Inventory | 23.54 | 11.65 | 23.92 | 7.95 | 7.06 | - | Upgrade
|
| Prepaid Expenses | 64.17 | 27.34 | 23.59 | 15.94 | 14.24 | 6.31 | Upgrade
|
| Restricted Cash | 1.75 | 1.75 | 1.75 | 1.4 | 1.4 | - | Upgrade
|
| Other Current Assets | 30.1 | 15.1 | 21.6 | 9.5 | - | - | Upgrade
|
| Total Current Assets | 1,272 | 667.8 | 737.96 | 467.28 | 690.9 | 230.32 | Upgrade
|
| Property, Plant & Equipment | 16.02 | 14.58 | 16.74 | 22.56 | 26.32 | 20.51 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | - | 0.26 | Upgrade
|
| Other Long-Term Assets | 36.7 | 45.91 | 0.09 | 0.09 | 0.09 | 0.09 | Upgrade
|
| Total Assets | 1,324 | 728.3 | 754.78 | 489.92 | 717.31 | 251.19 | Upgrade
|
| Accounts Payable | 10.34 | 11.45 | 10.4 | 8.69 | 5.5 | 7.43 | Upgrade
|
| Accrued Expenses | 151.57 | 108.48 | 68.27 | 37.93 | 25.81 | 25.61 | Upgrade
|
| Current Portion of Leases | 4.2 | 3.61 | 4.57 | 6.73 | 5.54 | 3.19 | Upgrade
|
| Total Current Liabilities | 166.11 | 123.55 | 83.24 | 53.36 | 36.85 | 36.22 | Upgrade
|
| Long-Term Leases | 13.51 | 13.33 | 15.47 | 18.68 | 23.6 | 19.96 | Upgrade
|
| Total Liabilities | 179.62 | 136.87 | 98.71 | 72.03 | 60.45 | 56.18 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 2,818 | 2,208 | 2,138 | 1,639 | 1,593 | 904.97 | Upgrade
|
| Retained Earnings | -1,675 | -1,617 | -1,477 | -1,221 | -937.1 | -710.1 | Upgrade
|
| Comprehensive Income & Other | 1.63 | 0.1 | -4.19 | -0.36 | 0.48 | 0.13 | Upgrade
|
| Shareholders' Equity | 1,145 | 591.42 | 656.07 | 417.89 | 656.86 | 195.01 | Upgrade
|
| Total Liabilities & Equity | 1,324 | 728.3 | 754.78 | 489.92 | 717.31 | 251.19 | Upgrade
|
| Total Debt | 17.71 | 16.94 | 20.04 | 25.41 | 29.14 | 23.14 | Upgrade
|
| Net Cash (Debt) | 988.85 | 481 | 571.86 | 386.93 | 628.31 | 200.87 | Upgrade
|
| Net Cash Growth | 107.94% | -15.89% | 47.80% | -38.42% | 212.80% | -42.20% | Upgrade
|
| Net Cash Per Share | 9.82 | 5.02 | 6.08 | 4.76 | 8.93 | 3.64 | Upgrade
|
| Filing Date Shares Outstanding | 106.02 | 96.81 | 95.28 | 93.59 | 80.92 | 66.13 | Upgrade
|
| Total Common Shares Outstanding | 106 | 96.38 | 94.83 | 81.89 | 80.46 | 55.51 | Upgrade
|
| Working Capital | 1,106 | 544.25 | 654.72 | 413.92 | 654.05 | 194.1 | Upgrade
|
| Book Value Per Share | 10.80 | 6.14 | 6.92 | 5.10 | 8.16 | 3.51 | Upgrade
|
| Tangible Book Value | 1,145 | 591.42 | 656.07 | 417.89 | 656.86 | 195.01 | Upgrade
|
| Tangible Book Value Per Share | 10.80 | 6.14 | 6.92 | 5.10 | 8.16 | 3.51 | Upgrade
|
| Machinery | - | - | - | 5.12 | 4.79 | 4.53 | Upgrade
|
| Leasehold Improvements | - | - | - | 1.24 | 1.24 | 1.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.